Insider Trading
Company officers and directors buying and selling their own stock, as reported to the SEC on Form 4.
16,432 open-market transactions — 2,564 purchases, 13,868 sales · 2006-08-28 to 2026-09-04-05:00
| Date | Ticker | Insider | Action | Shares | Price | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04-05:00 | ASPI | Mann Paul Elliot — Chairman and CEO | Sell | 83.8K | 4.10 | SEC |
| 2026-09-04 | ILMN | Meister Keith A. — Director | Sell | 100.7K | 218.39 | SEC |
| 2026-09-04 | NMIH | Pollitzer Adam — Chief Executive Officer | Sell | 172.7K | 44.86 | SEC |
| 2026-09-04 | CAI | Spetzler David Baxley — President | Sell | 119.2K | 24.76 | SEC |
| 2026-09-04 | ILMN | Meister Keith A. — Director | Sell | 11.4K | 219.18 | SEC |
| 2026-09-04 | ILMN | Meister Keith A. — Director | Sell | 7.5K | 217.28 | SEC |
| 2026-09-04 | RXT | Kandiah Gajakarnan Vibushanan — Chief Executive Officer | Sell | 498.7K | 3.21 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 4.0K | 357.57 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 4.0K | 357.57 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 3.4K | 359.39 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 3.4K | 359.39 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 3.3K | 356.37 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 3.3K | 356.37 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 3.2K | 358.42 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 3.1K | 358.42 | SEC |
| 2026-09-04 | ATRA | Cherry Brian N — Director | Buy | 104.2K | 9.60 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 2.3K | 360.47 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 2.3K | 360.46 | SEC |
| 2026-09-04 | CRM | Conway Craig — Director | Sell | 3.1K | 260.66 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 2.0K | 362.65 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 2.0K | 362.65 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 2.0K | 355.57 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 2.0K | 355.57 | SEC |
| 2026-09-04 | INOD | FORLENZA LOUISE C — Director | Sell | 10.0K | 55.01 | SEC |
| 2026-09-04 | XYZ | Eisen Anthony Mathew — Director | Sell | 6.0K | 82.51 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 1.4K | 364.48 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 1.3K | 364.48 | SEC |
| 2026-09-04 | RMNI | Ravin Seth A. — President, CEO & Chairman | Sell | 89.6K | 5.02 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 1.2K | 361.61 | SEC |
| 2026-09-04 | VCYT | Febbo Phillip G. — Chief Scientific & Med Officer | Sell | 10.4K | 42.89 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 1.2K | 361.61 | SEC |
| 2026-09-04 | LITE | Wupen Yuen — PRESIDENT, GLOBAL BUS. UNITS | Sell | 500 | 860.00 | SEC |
| 2026-09-04 | CRM | Conway Craig — Director | Sell | 1.4K | 260.50 | SEC |
| 2026-09-04 | KYMR | Adams Brian — Chief Legal Officer | Sell | 3.0K | 116.81 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 847 | 365.42 | SEC |
| 2026-09-04 | SCSC | Ford Brandy — SVP & Chief Accounting Officer | Sell | 5.3K | 57.43 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 826 | 365.41 | SEC |
| 2026-09-04 | EVC | ZEVNIK PAUL A — Director | Sell | 35.0K | 8.40 | SEC |
| 2026-09-04 | KYMR | Adams Brian — Chief Legal Officer | Sell | 2.1K | 117.57 | SEC |
| 2026-09-04 | ENOV | McDonald Damien — Chief Executive Officer | Buy | 13.0K | 19.15 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 573 | 363.34 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 565 | 363.34 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 520 | 354.54 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 520 | 354.54 | SEC |
| 2026-09-04 | STUB | Islam Nayaab — See Remarks | Sell | 24.6K | 6.69 | SEC |
| 2026-09-04 | DLTR | Stahl Stephanie — Director | Sell | 1.2K | 131.47 | SEC |
| 2026-09-04 | KRYS | Krishnan Krish S — President and CEO | Sell | 405 | 366.56 | SEC |
| 2026-09-04 | KRYS | Krishnan Suma — President, R&D | Sell | 399 | 366.56 | SEC |
| 2026-09-04 | KYMR | Adams Brian — Chief Legal Officer | Sell | 1.2K | 115.55 | SEC |
| 2026-09-04 | VCYT | Febbo Phillip G. — Chief Scientific & Med Officer | Sell | 2.7K | 43.66 | SEC |
| 2026-09-04 | AXIA3 | Gualda Sampaio Araujo Camila — See Remarks* | Sell | 10.8K | 10.74 | SEC |
| 2026-09-04 | VCYT | Chambers Rebecca — Chief Financial Officer | Sell | 2.5K | 42.81 | SEC |
| 2026-09-04 | VCYT | McGuire Annie — EVP, General Counsel | Sell | 2.2K | 42.79 | SEC |
| 2026-09-04 | EQH | Isaacs-Lowe Arlene — Director | Sell | 1.0K | 52.83 | SEC |
| 2026-09-04 | VCYT | Chambers Rebecca — Chief Financial Officer | Sell | 1.2K | 43.71 | SEC |
| 2026-09-04 | VCYT | McGuire Annie — EVP, General Counsel | Sell | 1.1K | 43.67 | SEC |
| 2026-09-04 | HAPN | Selleck Erin — Director | Sell | 2.1K | 17.41 | SEC |
| 2026-09-04 | UIS | Brown David Lawrence — VP, CAO, Corporate Controller | Sell | 10.6K | 2.54 | SEC |
| 2026-09-04 | EVCM | Remer Eric Richard — Director | Sell | 3.0K | 8.02 | SEC |
| 2026-09-04 | GLOO | THRIVENT FINANCIAL FOR LUTHERANS | Sell | 5.5K | 3.09 | SEC |
| 2026-09-04 | XOS | OSTERMANN DIETMAR — Director | Sell | 5.0K | 3.00 | SEC |
| 2026-09-04 | INTZ | Hinchcliffe Dion — Director | Sell | 15.0K | 0.78 | SEC |
| 2026-09-04 | ALEC | Wong-Sarad Grace — Principal Accounting Officer | Sell | 3.6K | 2.51 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 340 | 21.26 | SEC |
| 2026-09-04 | LPA | Marquina Javier — Director | Sell | 1.8K | 3.08 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 170 | 21.26 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 160 | 21.30 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 160 | 21.30 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 120 | 21.28 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 112 | 21.25 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.27 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.25 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.24 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.24 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.23 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.19 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 100 | 21.17 | SEC |
| 2026-09-04 | SCSC | Ford Brandy — SVP & Chief Accounting Officer | Sell | 34 | 58.04 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 90 | 21.31 | SEC |
| 2026-09-04 | FUSB | FIELD Robert C — Director | Buy | 113 | 16.45 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 80 | 21.20 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 70 | 21.29 | SEC |
| 2026-09-04 | FCF | Reske James R — EVP/Chief Financial Officer | Sell | 70 | 21.16 | SEC |
| 2026-09-04 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. — CEO | Buy | 9.8K | 0.05 | SEC |
| 2026-09-03-05:00 | ASPI | Mann Paul Elliot — Chairman and CEO | Sell | 83.8K | 3.92 | SEC |
| 2026-09-03-05:00 | NEGG | CHANG FRED FACHING — Director | Sell | 3.6K | 16.40 | SEC |
| 2026-09-03 | CAI | Spetzler David Baxley — President | Sell | 393.1K | 24.76 | SEC |
| 2026-09-03 | WBD | LOWE KENNETH W — Director | Sell | 200.0K | 28.35 | SEC |
| 2026-09-03 | WLDN | Brisbin Thomas Donald — Director | Sell | 58.8K | 88.14 | SEC |
| 2026-09-03 | SNOW | Kleinerman Christian — EVP, Product Management | Sell | 10.0K | 380.00 | SEC |
| 2026-09-03 | AFRM | Adkins Katherine — Chief Legal Officer | Sell | 41.7K | 75.53 | SEC |
| 2026-09-03 | ILMN | Meister Keith A. — Director | Sell | 14.2K | 217.29 | SEC |
| 2026-09-03 | ILMN | Meister Keith A. — Director | Sell | 13.7K | 219.41 | SEC |
| 2026-09-03 | ILMN | Meister Keith A. — Director | Sell | 13.3K | 216.38 | SEC |
| 2026-09-03 | PARR | Monteleone William — President and CEO | Sell | 26.8K | 83.00 | SEC |
| 2026-09-03 | ILMN | Meister Keith A. — Director | Sell | 10.0K | 221.55 | SEC |
| 2026-09-03 | CAI | Spetzler David Baxley — President | Sell | 84.9K | 25.32 | SEC |
| 2026-09-03 | ILMN | Meister Keith A. — Director | Sell | 9.7K | 218.33 | SEC |
| 2026-09-03 | AXSM | Jacobson Mark L. — Chief Operating Officer | Sell | 10.0K | 208.65 | SEC |
| 2026-09-03 | MIAX | Gallagher Thomas P. — Chairman & CEO | Sell | 47.0K | 42.43 | SEC |
What Form 4 actually tells you
Officers, directors and anyone holding more than 10% of a company must report trades in its stock to the SEC within two business days, on Form 4. The filings are public the moment they land, and every row above links to the original.
Buys and sells are not symmetric
This is the thing worth internalising. An insider sells for a hundred reasons that say nothing about the company — diversification, a house, a tax bill, or a pre-scheduled 10b5-1 plan set up months earlier. An insider buying on the open market with their own money has exactly one obvious motive.
Which is why this page shows only open-market purchases and sales. Form 4 also reports option grants, option exercises and shares withheld to cover taxes; those are compensation mechanics, and screens that fold them in produce noise that looks like signal.
Timing and limits
- Reported within two business days of the trade — fast by disclosure standards, but not instant.
- Some prices are blank in the original filing, usually for gifts or transfers at no stated price. Blank here means blank there; nothing is imputed.
- This holds a rolling recent window rather than all of EDGAR history. A full backfill is hundreds of thousands of requests and would be rude to the SEC's servers.
Where this comes from
Parsed directly from SEC EDGAR — the daily filing index, then each Form 4's XML. Public domain, no vendor in between, which is why the original filing can be linked from every row.